Inhibitory effects of retinoids on vascular endothelial growth factor production by cultured human skin keratinocytes

Dermatology

Volumn 199, Issue SUPPL. 1, 1999, Pages 25-27

  Lachgar, S ^a   Charveron M ^a   Gall, Y ^a   Bonafe J L ^a,b  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

^b CHU RANGUEIL   (France)

Author keywords

Retinaldehyde; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; RETINOIC ACID; RETINOID; RETINOL; VASCULOTROPIN;

CONFERENCE PAPER; CONTROLLED STUDY; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; KERATINOCYTE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN CULTURE; TOPICAL DRUG ADMINISTRATION;

EID: 0344172697     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000051374     Document Type: Conference Paper

References (14)

1. Neufeld G, Tessler S, Gitay-Goren H, Cohen T, Levi BZ: Vascular endothelial growth factor and its receptors. Prog Growth Fact Res 1994;5:89-97.
2. Plate KH, Breier G, Risau W: Molecular mechanisms of developmental and tumor angiogenesis (review). Brain Pathol 1994;4:207-218.
3. Folkman J: Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med 1995;1:27-31.
4. Ballaun C, Weninger W, Uthman A, Weich H, Tschachler E: Human keratinocytes express the three major forms of vascular endothelial growth factor. J Invest Dermatol 1995;104: 7-10.
5. Brown LF, Yeo KT, Berse B, Yeo TK, Senger DR, Dvorak HF, van de Water L: Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing. J Exp Med 1992;176: 1375-1379.
6. Detmar M, Brown LF, Claffey KP, Yeo KT, Kocher O, Jackman RW, Berse B, Dvorak HF: Overexpression of vascular permeability factor (vascular endothelial growth factor) in psoriasis. J Exp Med 1994;180:1141-1146.
7. Brown LF, Harrist TJ, Yeo KT, Stahle-Backdahl M, Jackman RW, Berse B, Tognazzi K, Dvorak HF, Detmar M: Increased expression of vascular permeability factor (vascular endothelial growth factor) in bullous pemphigoid, dermatitis herpetiformis, and erythema multiforme. J Invest Dermatol 1995;104:744-749.
8. Oikawa T, Hirotani K, Nakamura O, Shudo K, Hiragun A, Iwaguchi T: A highly potent anti-angiogenic activity of retinoids. Cancer Lett 1989;48:157-162.
9. Oikawa T, Okayasu I, Ashino H, Morita I, Murota S, Shudo K: Three novel synthetic retinoids, Re 80, Am 580 and Am 80, all exhibit anti-angiogenic activity in vivo. Eur J Pharmacol 1993;249:113-116.
10. Majewski S, Szmurlo A, Marczak M, Jablonska S, Bollag W: Synergistic effect of retinoids and interferon α on tumor-induced angiogenesis: Anti-angiogenic effect on HPV-harboring tumor cell lines. Int J Cancer 1994;57:81-85.
11. Lachgar S, Charvéron M, Aries MF, Gall Y, Bonafé JL: Inhibitory effects of retinoids on VEGF production by cultured human skin keratinocytes (abstract). J Invest Dermatol 1997; 109:455.
12. Weninger W, Rendl M, Mildner M, Tschachler E: Retinoids downregulate vascularendothelial growth factor/vascular permeability factor production by normal human keralinocytes. J Invest Dermatol 1998;111:907-911.
13. Clauss M, Gerlach M, Gerlach H, Brett J, Wang F, Familletti PC, Pan YC, Olander JV, Connolly DT, Stern D: Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration. J Exp Med 1990;172:1535-1545.
14. Gruber BL, Marchese MJ, Kew RI: Angiogenic factors stimulate mast-cell migration. Blood 1994;86:2488-2493.